0000950170-24-028216.txt : 20240307
0000950170-24-028216.hdr.sgml : 20240307
20240307183539
ACCESSION NUMBER: 0000950170-24-028216
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MANCHESTER KEITH S
CENTRAL INDEX KEY: 0001244828
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 24731829
MAIL ADDRESS:
STREET 1: C/O ROIVANT SCIENCES LTD.
STREET 2: 11-12 ST. JAMES'S SQUARE SUITE 1, 3RD FL
CITY: LONDON
STATE: X0
ZIP: SW1Y 4L
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
ownership.xml
4
X0508
4
2024-03-07
0001635088
Roivant Sciences Ltd.
ROIV
0001244828
MANCHESTER KEITH S
C/O ROIVANT SCIENCES LTD.
7TH FLOOR, 50 BROADWAY
LONDON
X0
SW1H 0DB
UNITED KINGDOM
true
false
false
false
false
Common Shares
2024-03-07
4
J
false
11077765
0.00
D
14646796
I
Held by QVT Deferred Compensation Holdings Ltd
Common Shares
2024-03-07
4
J
false
11325233
0.00
D
23105358
I
Held by QVT Financial Investment Cayman Ltd.
Common Shares
2024-03-07
4
J
false
5594064
0.00
D
6837266
I
Held by QVT Roiv Hldgs Onshore Ltd.
Common Shares
2024-03-07
4
J
false
2260661
0.00
D
2763126
I
Held by QVT P&E Roiv Hldgs Ltd.
Common Shares
1763772
D
On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. (together, "QVT Roiv"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration.
The reporting person is a shareholder of each of QVT Roiv, QVT DCH, QVT P&E and QVT FIC (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
Includes shares reporting person received as part of the distribution described in (1) above, which is exempted under both Rule 16a-9 and Rule 16a-13 as a change in form of beneficial ownership and (i) an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy (the "Equity Plan"), which vested on September 15, 2023 and (ii) an annual award of restricted stock units with respect to RSU granted pursuant to the Equity Plan, which is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date.
/s/ Keith Manchester
2024-03-07